We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




PET and CT Colonography Combines to Bring Comfort to Patients

By HospiMedica International staff writers
Posted on 01 Jul 2010
A new method that combines two imaging technologies detects polyps, but requires no sedatives or bowel preparation.

A study published in the June 2010 issue of the Journal of Nuclear Medicine (JNM) shows that positron emission tomography (PET)--a molecular imaging technique--combined with computer tomography (CT) colonography may provide a suitable alternative for detecting polyps and cancer in the colon. More...
This particular imaging method may be especially desirable for patients because it does not require sedation or bowel preparation.

"One of the first indications of colorectal cancer is often the presence of polyps, which are abnormal tissue growths on the inner lining of the colon or large intestine,” said Stuart A. Taylor, M.D., University College London (UK), and lead researcher of the study. "If these polyps are detected noninvasively and without the use of bowel preparation and sedatives, investigation can be much easier on patients who would otherwise undergo colonoscopies.”

Up to now, the conventional diagnostic modality for colorectal cancer and polyps has been colonoscopy, whereby a telescopic camera is introduced into the colon via the back passage and passed around the one to two meters of colon to look for abnormalities in the bowel lining. Although this technique is very effective, it is also invasive and can be uncomfortable for patients. Currently, patients empty their bowels using laxatives, may require sedation during the test and may need to take a day off from their normal activities. Strong laxatives can also be harmful to older patients by causing dehydration and disturbing their salt levels.

CT colonography (CTC) is an imaging technique that presents a promising, less invasive alternative to colonoscopy. The CTC scan provides images of the lining of the bowel, which has been gently distended with gas, without the need for sedatives. One potential advantage of CTC over colonoscopy is its ability to visualize the large bowel--without the patient having to take strong laxatives. PET scanning produces images of the uptake of blood sugar (glucose) by body tissues. Because cancerous cells tend to take up more blood sugar than normal tissue, these concentrations provide clear evidence of any abnormalities.

This study researched the effectiveness of using a combination of CTC and PET scans without any bowel preparation to detect significant abnormalities in the colon. Although other work has demonstrated that combined PET CTC is technically feasible, most have required patients to undergo complete bowel preparation and only a small number of patients have been studied. The current study is the largest to date investigating combined PET CTC in patients without any bowel preparation.

Fifty-six patients agreed to undergo a one-hour CTC and PET scan approximately two weeks before their scheduled colonoscopy. This was done without the use of laxatives. Patients were also asked to complete a questionnaire to see how they tolerated the tests and which ones they preferred.

The colonoscopy findings were then compared with the CTC scan on its own and with the CTC and PET scans combined. The study revealed that the combined PET CTC scans detected all the significant larger polyps found by the invasive colonoscopy technique. Moreover, most patients found the combined scan technique more comfortable and preferred it to colonoscopy.

"The work has shown that combined PET CTC is technically feasible, well tolerated by patients, and capable of achieving high diagnostic accuracy,” noted Dr. Taylor. "This test would be mainly used in patients less able to tolerate invasive investigations or the preparation required if physicians want to exclude any major pathology in the colon and abdomen.”

Colorectal cancer is one of the leading causes of cancer death in the Western world and affects approximately 6% of the population.

Related Links:
University College London



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.